Menogo-Sure HP

Menogo-Sure HP 75IU Injection is prescribed to treat infertility in women. It helps women who have trouble releasing an egg (anovulation), including those with polycystic ovarian syndrome (PCOS). It is also used for controlled ovarian stimulation in fertility treatments like IVF, ICSI, GIFT, or egg retrieval cycles.<br>

Doctors usually recommend Menogo-Sure HP 75IU Injection when simpler treatments (like clomiphene citrate) have not worked. Before starting, your doctor checks hormone levels, possible causes of infertility, and any underlying issues such as thyroid or adrenal problems to ensure hMG is safe and suitable for you.<br>

Menogo-Sure HP 75IU Injection requires close medical monitoring because it can overstimulate the ovaries in some people. Regular ultrasounds and blood tests help prevent complications. The first injection is usually given under medical supervision.<br>

Yes, Menogo-Sure HP 75IU Injection can cause ovarian hyperstimulation syndrome (OHSS). OHSS is a serious condition where the ovaries become swollen, and fluid can build up in the abdomen or chest. Symptoms may include abdominal pain, rapid weight gain, nausea, vomiting, breathing difficulty, or decreased urine output. Seek urgent medical care if these occur.<br>

Individuals should not use Menogo-Sure HP 75IU Injection if they have tumors of the pituitary gland or hypothalamus, ovarian, uterine, or breast cancer, unexplained vaginal bleeding, ovarian cysts not linked to PCOS, primary ovarian failure, or if they are pregnant or breastfeeding. Your doctor will assess for any conditions that make treatment unsafe or ineffective.<br>

Yes. Menogo-Sure HP 75IU Injection increases the growth of eggs, which raises the chance of twin or higher-order pregnancies. Your doctor monitors your ovarian response closely to minimize this risk.<br>

Women undergoing fertility treatments, including Menogo-Sure HP 75IU Injection, may have a higher risk of miscarriage or ectopic pregnancy, especially if they have a history of fallopian tube problems. Regular follow-ups help detect complications early.<br>

Yes. Before starting Menogo-Sure HP 75IU Injection, your doctor checks for conditions like hypothyroidism, adrenal problems, high prolactin, or any pituitary/hypothalamic tumors. These conditions must be managed before using hMG safely.<br>

Women with risk factors such as obesity (BMI > 30), family history of clots, or clotting disorders may have a higher chance of venous or arterial blood clots during treatment. Discuss your risk profile with your doctor.<br>

A very small number of women who have undergone multiple infertility treatments, including Menogo-Sure HP 75IU Injection, have reported ovarian or reproductive system tumors. It is not clear whether these are caused by the medicines or by fertility challenges themselves. Monitoring and medical guidance reduce risks.<br>

Yes. Menogo-Sure HP 75IU Injection may give positive results on doping tests. Using this medicine without a medical need can be harmful.

Serious side effects of Menogo-Sure HP 75IU Injection may include severe abdominal pain or swelling, difficulty breathing, sudden weight gain, severe headaches, or vision changes, signs of blood clots (leg pain, chest pain, shortness of breath), and allergic reactions like rash, swelling, or trouble breathing. Seek immediate medical attention if you experience any of these symptoms.<br>